Leber´s hereditary optic neuropathy: vision recovery due to spontaneous remission or Idebenone treatment outcome? - a case report / Neuropatia óptica hereditária da Leber: recuperação da visão devido a remissão espontânea ou resultado do tratamento com Idebenone? - um relato de caso

Authors

  • Glauco Almeida Brazilian Journals Publicações de Periódicos, São José dos Pinhais, Paraná
  • Juliano Parmigiani

DOI:

https://doi.org/10.34119/bjhrv5n2-237

Keywords:

optic neuropathy, Leber’s neuropathy, acute visual loss, genetic visual loss, idebenone.

Abstract

Leber’s Hereditary Optic Neuropathy (LHON) is a neurodegenerative disease that commonly affects young male leading to acute central visual loss – bilaterally in most cases. The patients carry DNA mutations that sometimes can express Leber’s disease symptons. Diagnosis is based on complementary exams but mostly expensive genetic studies. Treatment is still na on going process. The case of the young male patient reported here has the objective to highlight that in most countries, such as Brazil, public policies are needed to enable genetic medical diagnosis and treatment.

References

- Poincenot L, Pearson AL, Karanjia R. Demographics of a Large International Population of Patients Affected by Leber's Hereditary Optic Neuropathy. Ophthalmology. 2020 May;127(5):679-688. doi: 10.1016/j.ophtha.2019.11.014. Epub 2019 Nov 25. PMID: 31932089.

- Jankauskaitė E, Ambroziak AM, Hajieva P, Ołdak M, Tońska K, Korwin M, Bartnik E, Kodroń A. Testosterone increases apoptotic cell death and decreases mitophagy in Leber's hereditary optic neuropathy cells. J Appl Genet. 2020 May;61(2):195-203. doi: 10.1007/s13353-020-00550-y. Epub 2020 Mar 10. PMID: 32157656; PMCID: PMC7148285.

- Liutkeviciene R, Sidaraite A, Kuliaviene L, Glebauskiene B, Jurkute N, Aluzaite-Baranauskiene L, Gelzinis A, Zemaitiene R. A Typical Case Presentation with Spontaneous Visual Recovery in Patient Diagnosed with Leber Hereditary Optic Neuropathy due to Rare Point Mutation in MT-ND4 Gene (m.11253T>C) and Literature Review. Medicina (Kaunas). 2021 Feb 26;57(3):202. doi: 10.3390/medicina57030202. PMID: 33652663; PMCID: PMC7996816.

- Parisi V, Ziccardi L, Sadun F, De Negri AM, La Morgia C, Barbano L, Carelli V, Barboni P. Functional Changes of Retinal Ganglion Cells and Visual Pathways in Patients with Chronic Leber's Hereditary Optic Neuropathy during One Year of Follow-up. Ophthalmology. 2019 Jul;126(7):1033-1044. doi: 10.1016/j.ophtha.2019.02.018. Epub 2019 Feb 26. PMID: 30822445.

- Dawod PGA, Jancic J, Marjanovic A, Brankovic M, Jankovic M, Samardzic J, Potkonjak D, Djuric V, Mesaros S, Novakovic I, Abdel Motaleb FI, Kostic VS, Nikolic D. Whole Mitochondrial Genome Analysis in Serbian Cases of Leber's Hereditary Optic Neuropathy. Genes (Basel). 2020 Sep 2;11(9):1037. doi: 10.3390/genes11091037. PMID: 32887465; PMCID: PMC7565519.

- Ishikawa H, Masuda Y, Ishikawa H, Shikisima K, Goseki T, Kezuka T, Terao M, Miyazaki A, Matsumoto K, Nishikawa H, Gomi F, Mimura O. Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study. Jpn J Ophthalmol. 2021 Jan;65(1):133-142. doi: 10.1007/s10384-020-00789-2. Epub 2020 Nov 13. Erratum in: Jpn J Ophthalmol. 2021 Jan 6; PMID: 33185792.

- Hage R, Vignal-Clermont C. Leber Hereditary Optic Neuropathy: Review of Treatment and Management. Front Neurol. 2021 May 26;12:651639. doi: 10.3389/fneur.2021.651639. PMID: 34122299; PMCID: PMC8187781.

- Catarino, Claudia B.; Klopstock, Thomas. Use of Idebenone for the Treatment of Leber's Hereditary Optic Neuropathy. J. inborn errors metab. 2017 Sep 18; screen ; 5: e17001. doi: 10.1177/2326409817731112

- RAXONE 150 MG COMPRIMIDOS: Comprimido revestido por película.. Responsável técnico Santhera Pharmaceuticals. Alemanha: Santhera Pharmaceuticals (Deutschland) GmbH , 2015. Disponível em: https://www.ema.europa.eu/en/documents/product-information/raxone-epar-product-information_pt.pdf. Acesso em: 10 fev. 2022.

- Vignal-Clermont, C., Girmens, JF., Audo, I. et al. Safety of Intravitreal Gene Therapy for Treatment of Subjects with Leber Hereditary Optic Neuropathy due to Mutations in the Mitochondrial ND4 Gene: The REVEAL Study. BioDrugs 35, 201–214 (2021). https://doi.org/10.1007/s40259-021-00468-9

- Wang Y, Hu LF, Cui PF, Qi LY, Xing L, Jiang HL. Pathologically Responsive Mitochondrial Gene Therapy in an Allotopic Expression-Independent Manner Cures Leber's Hereditary Optic Neuropathy. Adv Mater. 2021 Oct;33(41):e2103307. doi: 10.1002/adma.202103307. Epub 2021 Aug 25. PMID: 34431574.

Downloads

Published

04/17/2022

How to Cite

ALMEIDA, G.; PARMIGIANI, J. Leber´s hereditary optic neuropathy: vision recovery due to spontaneous remission or Idebenone treatment outcome? - a case report / Neuropatia óptica hereditária da Leber: recuperação da visão devido a remissão espontânea ou resultado do tratamento com Idebenone? - um relato de caso. Brazilian Journal of Health Review, [S. l.], v. 5, n. 2, p. 6679–6686, 2022. DOI: 10.34119/bjhrv5n2-237. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/46615. Acesso em: 18 oct. 2026.

Issue

Section

Original Papers